Figure 2.
Potential therapeutic targets for GC liver metastasis. The inhibition of the CXCR4/CXCR7-CXCL12 axis in the liver, suppression of M1-type KCs to M2-type KCs conversion, and blockade the binding of receptors secreted by liver resident cells binding to receptors on GC cells might destroy the TME of liver metastasis.
